In the present study, we show that Hsp32 is expressed in leukemic cells in Ph+ and Ph− ALL, and that pharmacologic inhibitors of Hsp32 suppress the growth of imatinib-sensitive as well as imatinib-resistant ALL cells. The gene discussed is HMOX1; the disease is acute lymphoblastic leukemia.